@BowTiedPeptide that'd be really cool, if you want an extremely knowledgeable advisor on bioregulators specifically (and the many derivatives thereof) and someboody who works with high-end clientele / knows the demand landscape quite well, I can likely connect you
@BowTiedPeptide (1/n)
actually just went to DM you but it says only blue check and whatever, so I'll just share here -- the number of eCom operations and influencers that can access and market high-purity bioregulators is rapidly making it kind of pointless to try and compete on that basis, but
@BowTiedPeptide ey mayne we got some vendors and access to operations that can beat that purity by a mile (verified by third party tests), but the number of reputable shops out there has kind of reached the point where bioregulators of high purity are basically commoditized, at this point IMO
@ImperiumPaper@0xpostscryptum There's another view here where if you *were* looking to bring true equity markets on chain to trade 24/7, wouldn't you actually want it initially tested with the exact user base that will use the perps first to let the existing demand effectively subsidize further R&D?